Apollo Funds Invest $1.25B for 13% Minority Stake in McKesson's Medical-Surgical Unit
MCK sits 35% above its 52-week low of $637.
Summary
McKesson Corporation has announced a strategic partnership with Apollo Funds, which will invest $1.25 billion to acquire a 13% minority interest in McKesson's Medical-Surgical Solutions (MMS) business. The agreement values the MMS segment at an enterprise value of $13 billion, with McKesson retaining operating control and majority ownership. This significant investment and partnership for a core business unit is a positive development, potentially providing capital for growth initiatives and enhancing the strategic direction of the MMS segment. Traders will monitor how this partnership impacts McKesson's future financial performance and strategic focus.
At the time of this announcement, MCK was trading at $860.01 on NYSE in the Life Sciences sector, with a market capitalization of approximately $106.1B. The 52-week trading range was $637.00 to $999.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.